Where your body stores fat matters more than how much you weigh
A long-running study of nearly two thousand adults in Mississippi quietly reframes a question medicine has long asked imprecisely: not how much a person weighs, but where the weight lives and what it does once there. Researchers found that fat concentrated around the abdomen predicted heart failure far more reliably than the familiar body mass index, with inflammation serving as the biological messenger between belly fat and a damaged heart. The finding invites clinicians to look past the scale and toward the body's interior geography — and its inflammatory state — as a more honest map of cardiovascular risk.
- People with normal BMI readings are developing heart failure, exposing a quiet blind spot in how medicine has long assessed cardiovascular danger.
- Over seven years, 112 of nearly 2,000 participants developed heart failure — and waist circumference flagged the risk that body weight alone missed.
- Visceral fat behaves like a rogue organ, releasing inflammatory compounds that damage blood vessels, disrupt immunity, and scar heart tissue from within.
- Inflammation accounted for up to one-third of the link between belly fat and heart failure, giving researchers a measurable biological pathway to target.
- Clinicians are now being urged to add waist measurements and inflammation markers to routine care, catching vulnerable patients before symptoms ever appear.
A study presented at the American Heart Association's scientific sessions in Boston offers a finding that could quietly reshape preventive cardiology: where the body stores fat may matter more than how much fat it carries overall.
Tracking nearly 2,000 African American adults in the Jackson, Mississippi area over almost seven years, researchers found that waist measurements predicted heart failure far more reliably than BMI. Of the 1,998 participants, 112 developed heart failure during the follow-up period — and those with larger waists faced elevated risk even when their BMI appeared normal. The implication is unsettling: a person can look healthy on the scale and still carry significant cardiovascular danger.
The mechanism appears to be inflammation. Blood tests measuring high-sensitivity C-reactive protein revealed that higher inflammation levels strongly predicted heart failure over time. Inflammation accounted for roughly one-quarter to one-third of the connection between belly fat and heart failure — pointing to a biological pathway in which visceral fat triggers an inflammatory cascade that damages blood vessels and promotes scar tissue formation in the heart itself. Unlike the fat measured by BMI, visceral fat sits deep in the abdomen, wrapped around internal organs, and releases inflammatory compounds directly into the bloodstream.
Szu-Han Chen, the medical student who led the research at National Yang Ming Chiao Tung University in Taiwan, noted that some people develop heart failure despite appearing to maintain a healthy weight. Earlier identification through waist size and inflammation markers could allow clinicians to intervene before symptoms emerge. Dr. Sadiya Khan of Northwestern University echoed the call to integrate waist measurements into routine preventive care, while noting that future studies should examine whether reducing inflammation specifically can lower heart failure risk.
The American Heart Association has since launched a Systemic Inflammation Data Challenge to accelerate research into how inflammation drives heart disease. The broader message is plain: a normal number on the scale does not guarantee a normal risk profile. The shape of that weight — and the inflammatory state it produces — may tell the more important story.
A study presented this week at the American Heart Association's scientific sessions in Boston offers a clarification that could reshape how doctors assess heart failure risk: where your body stores fat matters more than how much you weigh overall.
Researchers tracking nearly 2,000 African American adults in the Jackson, Mississippi area over almost seven years found that measurements of fat concentrated around the waist—what scientists call visceral fat or central obesity—predicted heart failure far more reliably than body mass index, the standard metric most people know as BMI. During the follow-up period, 112 participants developed heart failure. Those with larger waist measurements faced elevated risk even when their BMI fell within what's considered normal range. The finding suggests that a person can look healthy on the scale and still carry significant cardiovascular danger.
The mechanism appears to be inflammation. When researchers measured high-sensitivity C-reactive protein in blood samples—a standard marker of systemic inflammation—they found that people with higher levels were substantially more likely to develop heart failure over time. Crucially, inflammation accounted for roughly one-quarter to one-third of the connection between belly fat and heart failure risk. This points to a biological pathway: visceral fat doesn't just add weight; it triggers an inflammatory cascade throughout the body that damages blood vessels, disrupts immune function, and promotes scar tissue formation in the heart itself.
Szu-Han Chen, the medical student who led the research at National Yang Ming Chiao Tung University in Taiwan, framed the implications plainly: some people develop heart failure despite appearing to maintain a healthy weight. By monitoring waist size and inflammation markers, clinicians could identify vulnerable individuals earlier and intervene with prevention strategies before symptoms emerge—potentially stopping the disease before it starts.
The distinction between BMI and waist circumference is not academic. BMI treats all weight the same, whether it's muscle, bone, or the metabolically active fat that accumulates around internal organs. Visceral fat, by contrast, sits deep in the abdomen, wrapped around the liver and other organs, and behaves like an endocrine organ itself, releasing inflammatory compounds directly into the bloodstream. The study measured both waist circumference and waist-to-height ratio; both independently predicted heart failure risk.
Dr. Sadiya Khan, chair of the American Heart Association's 2025 scientific statement on heart failure prevention and a cardiovascular epidemiologist at Northwestern University, emphasized that these findings argue for integrating waist measurements into routine preventive care. She noted that the research builds on earlier work showing that where fat accumulates matters for heart disease development, though she called for future studies to determine whether central adiposity has greater predictive power than other risk factors.
The study population—1,998 adults aged 35 to 84, with an average age of 58, enrolled between 2000 and 2004—was followed through the end of 2016. Researchers assessed body composition through multiple measures and tested blood samples for inflammation markers. One limitation: the researchers couldn't distinguish between different types of heart failure, so the findings apply broadly across the condition's various forms. Future work should examine whether reducing inflammation specifically can prevent or lower heart failure risk, and how visceral fat relates to different heart failure subtypes.
The American Heart Association has now launched a Systemic Inflammation Data Challenge to encourage researchers to collaborate on understanding how inflammation drives heart disease and related conditions. The message from this research is clear: a normal weight on the scale doesn't guarantee a normal risk profile. The shape of that weight, and the inflammatory state it produces, may tell a more important story.
Notable Quotes
Some people develop heart failure despite having a body weight that seems healthy. By monitoring waist size and inflammation, clinicians may be able to identify people with higher risk earlier.— Szu-Han Chen, lead researcher, National Yang Ming Chiao Tung University
Understanding upstream drivers of heart failure risk including central adiposity is key to recognizing and modifying risk.— Dr. Sadiya Khan, American Heart Association scientific statement chair
The Hearth Conversation Another angle on the story
Why does belly fat behave so differently from fat stored elsewhere on the body?
Visceral fat—the kind that wraps around your organs—is metabolically active in a way that subcutaneous fat, the kind under your skin, isn't. It releases inflammatory compounds directly into your bloodstream and affects your liver function. It's almost like a separate organ system.
So someone could have a normal BMI and still be at risk?
Exactly. BMI is just a ratio of weight to height. It doesn't distinguish between muscle and fat, or where that fat lives. You could be 170 pounds at five-foot-ten with a normal BMI, but if most of that weight is visceral fat around your middle, your heart failure risk is substantially higher than someone else at the same weight with different fat distribution.
What does inflammation actually do to the heart?
It damages the blood vessel walls, disrupts the immune system's normal function, and promotes scar tissue formation in the heart muscle itself. Over time, that scarring stiffens the heart and makes it less able to pump blood efficiently. That's heart failure.
If inflammation accounts for only a quarter to a third of the risk, what's driving the other two-thirds?
That's the honest answer we don't have yet. Visceral fat likely has other harmful effects beyond inflammation—it affects how your body handles glucose, how your hormones function, how your blood vessels respond. The inflammation pathway is just the part we can measure and understand right now.
Could someone reduce their heart failure risk by lowering inflammation without losing weight?
That's the crucial question the next round of research needs to answer. If you could reduce inflammation through diet, exercise, or medication while keeping the same weight, would that lower risk? We don't know yet. But it's a possibility that could change how we approach prevention.
Why does this matter for doctors right now?
Because they can start measuring waist circumference and inflammation markers in routine checkups. They can identify people at higher risk before symptoms appear. Prevention is always easier than treatment.